BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17097406)

  • 1. Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
    Ondo AL; Mings SM; Pestak RM; Shanler SD
    J Am Acad Dermatol; 2006 Dec; 55(6):1092-4. PubMed ID: 17097406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
    Arits AH; Spoorenberg E; Mosterd K; Nelemans P; Kelleners-Smeets NW; Essers BA
    Br J Dermatol; 2014 Dec; 171(6):1501-7. PubMed ID: 24749843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.
    Smith KJ; Germain M; Skelton H
    Dermatol Surg; 2001 Jun; 27(6):561-4. PubMed ID: 11442593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
    Schroeder TL; Sengelmann RD
    J Am Acad Dermatol; 2002 Apr; 46(4):545-8. PubMed ID: 11907505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
    Love WE; Bernhard JD; Bordeaux JS
    Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bowen's disease of the penis treated with topical imiquimod 5% cream.
    Taliaferro SJ; Cohen GF
    J Drugs Dermatol; 2008 May; 7(5):483-5. PubMed ID: 18505144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
    Litwin MS; Krementz ET
    Panminerva Med; 1974 Mar; 16(3):84-5. PubMed ID: 4449647
    [No Abstract]   [Full Text] [Related]  

  • 8. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial.
    Patel GK; Goodwin R; Chawla M; Laidler P; Price PE; Finlay AY; Motley RJ
    J Am Acad Dermatol; 2006 Jun; 54(6):1025-32. PubMed ID: 16713457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream.
    Goh MS
    Australas J Dermatol; 2006 Aug; 47(3):186-8. PubMed ID: 16867000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.
    Tiodorovic-Zivkovic D; Zalaudek I; Longo C; De Pace B; Albertini G; Argenziano G
    Eur J Dermatol; 2012; 22(4):579-80. PubMed ID: 22652500
    [No Abstract]   [Full Text] [Related]  

  • 12. Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
    Pehoushek J; Smith KJ
    Arch Dermatol; 2001 Jan; 137(1):14-6. PubMed ID: 11176654
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report.
    Orengo I; Rosen T; Guill CK
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S225-8. PubMed ID: 12271283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical therapy for actinic keratoses: current and evolving therapies.
    Weinberg JM
    Rev Recent Clin Trials; 2006 Jan; 1(1):53-60. PubMed ID: 18393780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extramammary Paget's disease resistant to surgery and imiquimod monotherapy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic acid: a case report.
    Ye JN; Rhew DC; Yip F; Edelstein L
    Cutis; 2006 Apr; 77(4):245-50. PubMed ID: 16706242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
    Gill VL; Bergman PJ; Baer KE; Craft D; Leung C
    Vet Comp Oncol; 2008 Mar; 6(1):55-64. PubMed ID: 19178663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
    Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P
    Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy.
    Smith KJ; Germain M; Skelton H
    Dermatol Surg; 2001 Feb; 27(2):143-6. PubMed ID: 11207687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ.
    Queen D; Trager MH; Fan W; Gordon ER; Samie FH
    Arch Dermatol Res; 2024 May; 316(6):220. PubMed ID: 38787403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
    Oster-Schmidt C
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):93-5. PubMed ID: 14678542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.